Docstoc

Celtic Pharma Welcomes the Results of the Sale Process of Inspiration Biopharmaceutical’s Hemophilia Assets to Cangene Corporation (TSX: CNJ)

Document Sample
Celtic Pharma Welcomes the Results of the Sale Process of Inspiration Biopharmaceutical’s Hemophilia Assets to Cangene Corporation (TSX: CNJ) Powered By Docstoc
					
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:2
posted:2/7/2013
language:Japanese
pages:3
Description: HAMILTON, Bermuda & LONDON & NEW YORK--(BUSINESS WIRE)--Celtic Pharma records today's announcement by Inspiration Biopharmaceuticals that it has concluded the sale of its hemophilia product portfolio for an aggregate consideration that could exceed $1bn. img border='0' t
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.